Hints and tips:
Related Special Reports
Related Topics
GQG Partners argues that pharma group has performed strongly under long-serving chief
Shareholder advisory groups say potential £18.7mn payout is excessive
Michel Demaré in FT hits out at ISS and Glass Lewis for applying ‘double standards’ after they opposed CEO pay package
Drugmaker releases promising trial results for a pill and expects to enter China this year
Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value
Swiss pharma group has jettisoned 16 drugs that ‘don’t have the promise to be transformative medicines’
Ochre Bio partnering with Germany’s Boehringer Ingelheim on treatments that will harness the organ’s capacity to regenerate
Pfizer’s Emblaveo to be aimed at some of the most dangerous drug-resistant bacteria
Continent’s drugmakers need to pay up to attract and retain talent, says Pascal Soriot
Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform
Factory inspectors refuse to visit country over fears they could fall foul of tightened rules
Xylazine, commonly used to sedate animals, found cut with heroin, counterfeit tablets and cannabis vapes, study finds
Record shortages of common drugs have countries scrambling for alternatives while patients skip treatments
Report from Nuffield Trust health think-tank highlights impact of leaving EU on medicine supply chains
Almost 36 per cent of shareholders voted against a £1.8mn rise for the pharma group’s boss
Danish group seeks to branch out from diabetes and weight loss drugs with Cardior acquisition
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
International Edition